What is the recommended approach to assess and manage a patient presenting with breathlessness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Approach to Breathlessness

Begin by immediately assessing for life-threatening causes while measuring oxygen saturation with pulse oximetry and vital signs, then tailor oxygen therapy to target 94-98% for most patients or 88-92% for those at risk of hypercapnic respiratory failure, while simultaneously positioning the patient upright and implementing non-pharmacological measures. 1

Immediate Assessment and Stabilization

Life-Threatening Evaluation

  • Tap the patient's shoulder and shout "Are you all right?" to assess responsiveness, while simultaneously checking for absent or abnormal breathing (gasping does not count as normal breathing). 1
  • If unresponsive with no breathing or only gasping, activate emergency response and begin CPR immediately—healthcare providers should check for a pulse taking no more than 10 seconds, and if no definite pulse is felt, start chest compressions. 1
  • Ensure scene safety before approaching the patient. 1

Vital Signs and Oxygen Saturation

  • Measure oxygen saturation using pulse oximetry immediately in all patients presenting with breathlessness. 1, 2
  • Check respiratory rate, heart rate, and blood pressure to assess severity. 1, 2
  • Record oxygen saturation, delivery system, and flow rate on patient monitoring charts. 2

Common Pitfall: Pulse oximetry has limitations—in stable COPD patients undergoing long-term oxygen therapy assessment, SpO2 >88% missed 10% of patients with severe hypoxemia (PaO2 ≤55 mm Hg), including 2.5% with SpO2 >92% (occult hypoxemia). 3 This rate increases to 13% false negatives and 5% occult hypoxemia in active smokers. 3 Consider arterial blood gas measurement if the patient appears more unwell than the SpO2 suggests or if there is clinical concern about hypercapnia. 2

Risk Stratification for Oxygen Therapy

Patients WITHOUT Risk of Hypercapnic Respiratory Failure

  • Target oxygen saturation: 94-98% 4, 1, 2
  • Start oxygen via nasal cannula (1-4 L/min) or simple face mask (5-10 L/min). 1

Patients WITH Risk of Hypercapnic Respiratory Failure

  • Target oxygen saturation: 88-92% 4, 1, 2
  • Use controlled oxygen via Venturi mask (24-28%). 1

Risk factors for hypercapnic respiratory failure include: 4, 2

  • COPD (especially patients >50 years, long-term smokers with chronic breathlessness on minor exertion) 4
  • Patients already on long-term oxygen therapy 4
  • Morbid obesity (BMI >40 kg/m²) 4
  • Neuromuscular disorders (especially if wheelchair-bound) 4
  • Severe kyphoscoliosis or ankylosing spondylitis 4
  • Cystic fibrosis 2
  • Chest wall deformities 2
  • Bronchiectasis with fixed airflow obstruction 4
  • Home mechanical ventilation 4
  • Overdose of opioids, benzodiazepines, or respiratory depressants 4

Critical Warning: If a patient with COPD is found to have respiratory acidosis due to excessive oxygen therapy (PO2 >10 kPa or 75 mm Hg), do NOT discontinue oxygen immediately—oxygen levels will fall significantly over 1-2 minutes while carbon dioxide takes much longer to correct. 4 Instead, step down to 28% or 35% oxygen from a Venturi mask, or 1-2 L/min from nasal cannulae, targeting 88-92% saturation. 4

Non-Pharmacological Interventions

Positioning

  • Sit the patient upright to increase peak ventilation and reduce airway obstruction. 1
  • Have the patient lean forward with arms bracing a chair or knees with upper body supported to improve ventilatory capacity. 1
  • For pregnant women >20 weeks gestation, use left lateral positioning to avoid aortocaval compression. 2

Breathing Techniques

  • Teach pursed-lip breathing: inhale through nose for several seconds with mouth closed, then exhale slowly through pursed lips for 4-6 seconds. 1
  • Instruct patient to relax and drop shoulders to reduce the hunched posture associated with anxiety. 1
  • Consider early involvement of physiotherapists for breathing techniques. 2

Hand-Held Fan

  • A hand-held fan should be tried as first-line treatment for breathlessness when oxygen saturation is normal (SpO2 ≥94%). 4, 2
  • This simple intervention should be attempted before oxygen therapy in non-hypoxemic patients. 4

Airway Management (If Needed)

  • Open airway using head tilt-chin lift maneuver: place hand on forehead and gently tilt head back while lifting chin with fingertips. 1
  • Avoid head tilt if trauma to the neck is suspected. 1
  • Give 2 effective rescue breaths after ensuring head tilt and chin lift, pinching nose closed, and creating a good seal around the mouth—each breath should take 1.5-2 seconds and make the chest rise. 1

Pharmacological Management

Opioids for Refractory Breathlessness

  • Low-dose opioids should be considered for relief of breathlessness, particularly when chronic breathlessness persists despite optimal treatment of underlying pathophysiology. 4, 2
  • Oral low-dose sustained release morphine is licensed for chronic breathlessness due to COPD, heart failure, or cancer in Australia—start at 10 mg per day (2.5 mg immediate release four times daily, 5 mg modified release twice daily, or 10 mg modified release once daily). 4
  • In dose increment studies, 63% of participants achieved clinically important improvement, with 67% of responders benefiting at 10 mg per day, 25% requiring escalation to 20 mg, and 8% requiring 30 mg per day. 4

Evidence Note: Data on opioids in heart failure are conflicting for short-term use but promising for longer-term use. 4 Most evidence for opioid efficacy comes from stable COPD populations. 4

Anxiety Management

  • Treat anxiety which may contribute to the sensation of breathlessness. 2

Special Populations

Palliative Care Patients

  • Oxygen therapy should be restricted to patients with SpO2 consistently <90% or those reporting significant relief from oxygen. 4, 2
  • In non-hypoxemic patients, try opioids and non-pharmacological measures (including hand-held fan) before oxygen. 4, 2
  • Oxygen therapy should not be continued in the absence of patient benefit or where disadvantages (discomfort of masks/cannulae, drying of mucous membranes) outweigh symptomatic benefit. 4
  • In the last few days of life with comfort-focused care, there is no role for monitoring oxygen saturation—if the patient appears comfortable, oxygen levels are irrelevant. 4

Pregnant Patients

  • For women >20 weeks pregnant with hypoxemia and reduced consciousness or requiring respiratory/cardiovascular support, manage with left lateral tilt or manual uterine displacement to improve cardiac output and oxygen delivery. 4
  • Oxygen during labor is only required when there is maternal hypoxemia (SpO2 <94%)—routine supplemental oxygen during uncomplicated labor has weak evidence of fetal harm. 4

Monitoring and Reassessment

  • Reassess frequently if breathlessness persists despite interventions. 1, 2
  • Seek urgent medical advice if: patient appears to need increasing oxygen therapy, there is a rising National Early Warning Score (NEWS), or signs of respiratory deterioration are present. 1, 2
  • For chronically hypoxemic patients with a clinical exacerbation associated with a ≥3% fall in oxygen saturation on their usual oxygen therapy, assess in hospital with blood gas estimations. 4
  • Consider arterial blood gas if SpO2 ≤94% to warrant evaluation for severe hypoxemia, especially in active smokers where SpO2 overestimates oxygenation. 3

References

Guideline

Initial Management of Breathlessness

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Breathlessness

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.